BIL0062233 TEST REPORT

Name : Sandra CID : BIL0062233

Age / Gender : 26 Years / Female Registered on : 2-May-2021 / 11:32 AM
Ref.By : .. Collected on : 2-May-2021 / 11:33 AM
Referral Dr : - Reported on : 3-May-2021 / 10:22 AM
DEPARTMENT OF MOLECULAR PATHOLOGY
SARS-CoV-2 Detection By RT PCR
Investigation Result Biological Reference Interval
Specimen Type: Nasopharyngeal & Oropharyngeal Swabs
SARS-CoV-2 (COVID-19) POSITIVE
Method:Real Time PCR
Cycle Threshold (Ct) values
Target ORF1ab gene Undetermined < or = 35 : Positive
> 35 or Undetermined : Negative
Ct value is for informative purpose only
Target N gene Undetermined < or = 35 : Positive
> 35 or Undetermined : Negative
Ct value is for informative purpose only

INTERPRETATION:
The SARS-CoV-2 RT-PCR test is a real-time test based on the reverse transcription polymerase chain reaction (RT-PCR) for
the qualitative detection of nucleic acid from SARS-CoV-2 in samples of the upper respiratory tract (Nasopharyngeal &
Oropharyngeal Swabs) collected from individuals suspected by their healthcare provider to have COVID-19, belonging to a risk
cohort, or having been in contact with a confirmed COVID-19 patient. The results are used to identify SARS-CoV-2 RNA, which
is usually detectable in naso/oro-pharyngeal samples during the acute phase of the infection. The SARS-CoV-2 RT-PCR assay
targets two specific regions of the SARS-CoV-2 virus genome to guarantee unequivocal detection of the virus:

• Positive (Detectable) Test Result - Amplification of both targets reflects positive (detectable) test result. Positive
results indicate the presence of SARS-CoV-2 RNA, and clinical correlation with patient history and other diagnostic
information is highly recommended to determine the patient's infection status. Positive results do not rule out bacterial
infection or co-infection with other viruses.
• Negative (Non-Detectable) Test Result - Amplification of neither target reflects a negative (non-detectable) test
results. Negative results does not rule out SARS-CoV-2 infection and should not be used as the sole basis for patient
management decisions. Presence of inhibitors, mutations and insufficient RNA may lead to false negative results.
Repeat sampling and testing of lower respiratory specimen is strongly recommended in severe or progressive disease.

NOTE:

1. ICMR Regd No. for COVID-19 testing: OPERDIAHYDT

2. Kindly consult referring Physician / Authorized hospitals for appropriate follow up.

3. Test conducted on Nasopharyngeal & Oropharyngeal Swabs.

4. All results should be correlated with other clinical and radio graphical findings.

5. Ct values provided in the result are informative purpose only and have no diagnostic importance.

6. Ct Values differ with viral load, collection process, sample transportation, different Kits, different labs.

--- End Of Report ---

Dr.R. VANISHREE M.D

CONSULTANT MICROBIOLOGIST

*Indicates NABL MC-3808 accredited parameter

Page 1 of 1